A
Antonio Addis
Researcher at Mario Negri Institute for Pharmacological Research
Publications - 117
Citations - 3552
Antonio Addis is an academic researcher from Mario Negri Institute for Pharmacological Research. The author has contributed to research in topics: Pregnancy & Population. The author has an hindex of 25, co-authored 101 publications receiving 3258 citations. Previous affiliations of Antonio Addis include University of Toronto & Ministero della Salute.
Papers
More filters
Journal ArticleDOI
Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies
Lisa Dolovich,Antonio Addis,J. M. R. Vaillancourt,J. D. B. Power,Gideon Koren,Thomas R. Einarson +5 more
TL;DR: Pooled data from cohort studies showed no association between fetal exposure to benzodiazepines and the risk of major malformations or oral cleft, but on the basis of pooled data from case-control studies, however, there was a significant increased risk for major mal Formations or Oral cleft alone.
Journal ArticleDOI
Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: Evidence from a meta-analysis
Michael Iskedjian,Thomas R. Einarson,Linda MacKeigan,Neil H. Shear,Neil H. Shear,Antonio Addis,Nicole Mittmann,A.Lane Ilersich +7 more
TL;DR: The results of this meta-analysis demonstrate that with antihypertensive medications, QD dosing regimens are associated with higher rates of adherence than either BID or MDD regimens.
Journal ArticleDOI
Pregnancy Outcome Following Gestational Exposure to Venlafaxine: A Multicenter Prospective Controlled Study
Adrienne Einarson,Bumn Fatoye,Moumita Sarkar,Sharon Voyer Lavigne,Joanne Brochu,Christina D. Chambers,Pierpaolo Mastroiacovo,Antonio Addis,Doreen Matsui,Lavínia Schüler,Thomas R. Einarson,Gideon Koren +11 more
TL;DR: The results suggest that the use of venlafaxine during pregnancy does not increase the rates of major malformations above the baseline rate of 1%-3%.
Journal ArticleDOI
Pregnancy Outcome Following Gestational Exposure to Fluoroquinolones: a Multicenter Prospective Controlled Study
Ronen Loebstein,Antonio Addis,Elaine Ho,Roseann Andreou,Suzanne R. Sage,Alan E. Donnenfeld,Betsy Schick,Maurizio Bonati,Myla E Moretti,Arieh Lalkin,Anne Pastuszak,Gideon Koren +11 more
TL;DR: It is concluded that the use of fluoroquinolones during embryogenesis is not associated with an increased risk of major malformations and the higher rate of therapeutic abortions observed in quinolone-exposed women compared to that for their controls may be secondary to the misperception of a major risk related to quinoline use during pregnancy.
Journal ArticleDOI
Impact of body mass index and obesity on clinical response to systemic treatment for psoriasis. Evidence from the Psocare project.
Luigi Naldi,Antonio Addis,Sergio Chimenti,Alberto Giannetti,Mauro Picardo,Carlo Tomino,Mara Maccarone,Liliane Chatenoud,Paola Bertuccio,Eugenia Caggese,Rosanna Cuscito +10 more
TL;DR: The BMI affects the early clinical response to systemic treatment for psoriasis and the impact of the BMI did not show remarkable variations according to the drug prescribed at entry.